COMP <GO>
EMN vs SOLS // EV/EBITDA & P/E VALUATION
Eastman Chemical Company (NYSE) VS. Solstice Advanced Materials Inc. (NASDAQ) • 15-METRIC TALLY: EMN 6
— SOLS 8
▲ EV/EBITDA & P/E VALUATION LEADER: EMN
LAST: $66.53 (-2.06%) • MKT CAP: $7.77B
valuation
10.9x
LAST: $60.55 (-3.21%) • MKT CAP: $9.94B
valuation
19.8x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (EMN VS. SOLS)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | EMN | SOLS | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 21.10% | 32.20% | -11.10 | SOLS | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 4.80% | 8.00% | -3.20 | SOLS | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 10.9x | 19.8x | -8.90 | EMN | /valuation <GO> |
| Free Cash Flow Yield | 5.46% | 1.20% | +4.26 | EMN | /fcf-yield <GO> |
| Operating Margin | 6.60% | 7.40% | -0.80 | SOLS | /operating-margins <GO> |
| Net Profit Margin | 5.40% | 6.10% | -0.70 | SOLS | /net-margins <GO> |
| Revenue Growth (YoY) | -6.70% | 3.10% | -9.80 | SOLS | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 4.90% | 11.50% | -6.60 | SOLS | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.28 | 2.39 | -0.11 | SOLS | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 5/9 | +1.00 | EMN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 60.3 | 55.0 | +5.30 | EMN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 1.01 | +0.05 | EMN | /macro-sensitivity <GO> |
| Forward P/E Multiple | 15.3x | 39.0x | -23.70 | EMN | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.77B | $9.94B | -$2.17B | SOLS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | EMN REV | SOLS REV | EMN GROSS % | SOLS GROSS % | EMN FCF | SOLS FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $8.75B | $3.89B | 21.1% | 32.2% | $424.0M | $119.0M |
| FY 2024 | $9.38B | $3.77B | 24.4% | 34.6% | $688.0M | $546.0M |
| FY 2023 | $9.21B | $3.65B | — | — | $959.5M | $595.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
EMN // BETA 1.06
SOLS // BETA 1.01